What is the dosage of Otezla?

Otezla is available in 7 dosages, including 10 mg Tab, mixed Pack, 30 mg Tab, 20 mg Tab, mixed Pack, mixed Pack and mixed Pack

What does Otezla treat?

Otezla treats Arthritis, Psoriatic

What is Otezla made of?

Otezla contains apremilast which is a Phosphodiesterase 4 Inhibitor

How is Otezla administered?

Otezla is administered as a Oral Pill or Pack

What is Otezla mechanism of action?

Otezla mechanism of action is Phosphodiesterase 4 Inhibitors

Otezla Prescribing & Dosing Schedule

Dosage & Administration

To reduce the risk of gastrointestinal symptoms, titrate to recommended dosage as follows:

* Adults with Plaque Psoriasis, Psoriatic Arthritis, or Behçet's Disease
* See Table 1 for the initial titration schedule. Recommended maintenance dosage is 30 mg twice daily

* Pediatric Patients 6 Years of Age and Older and Weighing at Least 20 kg with Moderate to Severe Plaque Psoriasis
* See Table 2 for the initial titration schedule
* For patients weighing 50 kg or more: Recommended maintenance dosage is 30 mg twice daily
* For patients weighing 20 kg to less than 50 kg: Recommended maintenance dosage is 20 mg twice daily

* Dosage in Severe Renal Impairment:
* Adult Patients: For initial dosage titration, titrate using only morning schedule listed in Table 1 and skip afternoon doses. Recommended maintenance dosage is 30 mg once daily
* Pediatric Patients 6 Years of Age and Older and Weighing at Least 20 kg with Moderate to Severe Plaque Psoriasis: For initial dosage titration, titrate using only morning schedule for appropriate body weight category in Table 2 and skip afternoon doses
* For patients weighing 50 kg or more: Recommended maintenance dosage is 30 mg once daily
* For patients weighing 20 kg to less than 50 kg: Recommended maintenance dosage is 20 mg once daily

Get Your Patient on Otezla

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Dosage & Administration

Get Your Patient on Otezla

Otezla Prescribing Information

Otezla PubMed™ News

Otezla FAQs